ZFYVE28 Knockout BV-2 Cell Line
Cat.No.:
EDC90014
Species:
Mouse
Cell Name:
BV-2
Gene:
ZFYVE28
Gene ID:
57732
Size:
1×10⁶cells
ZFYVE28 Knockout BV-2 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC90014 |
|---|---|
| Product Name | ZFYVE28 Knockout BV-2 Cell Line |
| Species | Mouse |
| Cell Line | BV-2 |
| Cellosaurus ID | CVCL_0182 |
| Gene ID | |
| Gene |
ZFYVE28 |
| Summary |
Enables phosphatidylinositol-3-phosphate binding activity. Involved in negative regulation of epidermal growth factor-activated receptor activity. Located in cytosol and early endosome membrane. [provided by Alliance of Genome Resources, Jul 2025]
|
| Digestion Time | 1-2 min |
| Morphology | Semi-Suspension, Semi-Adherent |
| Passage Ratio | 1:3 |
| Complete Culture Medium | DMEM + 10% FBS + 1% GlutaMAX™ |
| Freezing Medium | 70% Complete medium + 20% FBS + 10% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: BV-2 | STR Info (Cell bank) Cell Line: BV-2 | ||||
| Allele1 | Allele2 | Allele3 | Allele1 | Allele2 | Allele3 | |
| 1-1 | 16 | 17 | 16 | 17 | ||
| 1-2 | 19 | 19 | ||||
| 2-1 | 16 | 16 | ||||
| 3-2 | 14 | 14 | ||||
| 4-2 | 20.3 | 20.3 | ||||
| 5-5 | 17 | 17 | ||||
| 6-4 | 18 | 18 | ||||
| 6-7 | 15 | 15 | ||||
| 7-1 | 26.2 | 26.2 | ||||
| 8-1 | 16 | 16 | ||||
| 11-2 | 16 | 16 | ||||
| 12-1 | 17 | 17 | ||||
| 13-1 | 17.1 | 17.1 | ||||
| 15-3 | 22.3 | 23.3 | 24.3 | 22.3 | 23.3 | 24.3 |
| 17-2 | 15 | 15 | ||||
| 18-3 | 16 | 17 | 16 | 17 | ||
| 19-2 | 13 | 13 | ||||
| X-1 | 27 | 27 | ||||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying ZFYVE28 function, ZFYVE28 Knockout BV-2 Cell Line or ZFYVE28 overexpression BV-2 Cell Line?
The choice depends on the experimental question. The Knockout line is appropriate for asking whether ZFYVE28 is required for endosomal sorting, trafficking, or microglial functions such as phagocytosis. Overexpression is appropriate when asking whether forced ZFYVE28 expression is sufficient to alter endosomal compartment dynamics or to modulate inflammatory signaling.
For an emerging factor with limited prior functional characterization, the EDITGENE Knockout line is the more conservative starting point — loss-of-function phenotypes provide clearer interpretive ground than overexpression artifacts, which are common for FYVE domain proteins due to their membrane recruitment behavior. Rescue with wild-type or FYVE-domain mutant constructs is particularly valuable here for assigning function to the phosphoinositide-binding domain.
What are the application scenarios for this model?
Primary applications:
• Endosomal localization studies: fluorescence microscopy co-localization with EEA1, Rab5, or Rab7 markers to assess whether ZFYVE28 loss disrupts endosomal compartment identity or dynamics.
• Trafficking assays: receptor internalization and degradation kinetics to quantify trafficking pathway integrity.
• Microglial functional assays: phagocytosis assays and inflammatory stimulation (LPS, cytokine treatment) to assess downstream consequences of endosomal pathway disruption on innate immune signaling.
• Transcriptomic analysis: RNA-seq to identify transcriptional changes associated with ZFYVE28 loss in a microglial background.
EDITGENE recommends this model for researchers investigating endosomal sorting, vesicular trafficking, and microglial biology.
Is this ZFYVE28 Knockout BV-2 Cell Line compatible with overexpression rescue experiments?
Yes. As a FYVE domain protein, ZFYVE28 rescue experiments require specific design considerations:
• Construct design: use a codon-modified ZFYVE28 sequence. Tag position is critical — the FYVE domain mediates membrane recruitment via phosphoinositide binding, and N-terminal tags can disrupt this function. C-terminal tagging is strongly preferred.
• Domain mutant rescue: a FYVE domain-binding-defective mutant (typically a conserved cysteine mutation that abolishes Zn²⁺ coordination) is essential as a specificity control. This distinguishes phenotypes dependent on endosomal recruitment from those mediated by other regions of the protein.
• Localization validation: confirm that exogenous wild-type ZFYVE28 recovers endosomal localization (co-staining with EEA1 or Rab5) before assessing functional rescue.
• Delivery method: BV-2 is a partially adherent murine microglial line with moderate transfection efficiency. Lentiviral transduction is the recommended approach; transient transfection is acceptable for short-term localization assays but not for inflammatory stimulation experiments requiring stable expression.
Polyclonal rescue pools are generally adequate for BV-2 given its phenotypic homogeneity in inflammatory assays.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.